Small Cell Lung Cancer research hub

A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

This study tests new medicines, obrixtamig and ZL-1310, for advanced lung and other neuroendocrine cancers. It aims to find a safe dose and see how they work, especially when combined with another drug to help your immune system fight cancer.